BRIEF published on 08/14/2026 at 11:35, 11 days 18 hours ago Innate Pharma Announces Upcoming Conference Call and Webcast Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
PRESS RELEASE published on 08/14/2026 at 11:30, 11 days 18 hours ago Inside Information / Other news releases Innate Pharma to host conference call and webcast with key executives discussing latest updates. Event details available on company website Conference Call Biotechnology Webcast Immunotherapy Innate Pharma
BRIEF published on 08/14/2026 at 10:32, 11 days 19 hours ago Innate Pharma Announces €30 Million Share Offering Biotechnology Investment Share Offering Innate Pharma ADC Portfolio
PRESS RELEASE published on 08/14/2026 at 10:27, 11 days 19 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) Innate Pharma prices €30 million offering of Ordinary Shares at €1.70 per share in Marseille, France. Proceeds will fund clinical development and ADC portfolio advancement Ordinary Shares Clinical Development Offering Innate Pharma ADC Portfolio
BRIEF published on 08/13/2026 at 22:05, 12 days 8 hours ago Innate Pharma Launches €22.5 Million Share Offering Euronext Paris Clinical Development Share Offering Innate Pharma Institutional Buyers
PRESS RELEASE published on 08/13/2026 at 22:00, 12 days 8 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) Innate Pharma announces proposed offering of ordinary shares worth approximately t €22.5 million, anchored by global coordinator Stifel, for continued clinical development and corporate purposes Ordinary Shares Clinical Development Offering Innate Pharma Stifel
BRIEF published on 08/10/2026 at 08:35, 15 days 21 hours ago Innate Pharma Advances Lacutamab into Phase 3 Trial with Sobi Innate Pharma Lacutamab Phase 3 TELLOMAK-3 Markus Jensen Sobi Partnership
BRIEF published on 05/19/2026 at 07:05, 3 months 6 days ago Innate Pharma to Attend Jefferies Global Healthcare Conference Biotechnology Cancer Treatment Immunotherapy Innate Pharma Jefferies Conference
BRIEF published on 05/19/2026 at 07:05, 3 months 6 days ago Innate Pharma at the Jefferies Global Healthcare Conference Immunotherapy Cancer Innate Pharma Therapeutic Antibodies Jefferies Conference
PRESS RELEASE published on 05/19/2026 at 07:00, 3 months 6 days ago Inside Information / Other news releases Innate Pharma to participate in Jefferies Global Healthcare Conference on June 2-4, 2026 in New York, United States. Developing immunotherapies for cancer patients Biotechnology Innate Pharma Jefferies Global Healthcare Conference Immunothérapies Cancer Patients
Published on 08/25/2026 at 23:05, 7 hours 17 minutes ago Faraday Copper Shareholders Approve Share Issuance in Connection with the Acquisition of the San Manuel Project
Published on 08/25/2026 at 15:00, 15 hours 22 minutes ago Four Nines Gold Intersects Hydrothermal Breccia in First Three Holes at Hayden Hill
Published on 08/25/2026 at 14:30, 15 hours 52 minutes ago First Breach Completes First Flight of Drone Prototype and Advances American-Made Manufacturing Through Hellbender Agreement
Published on 08/25/2026 at 14:30, 15 hours 52 minutes ago Tintina Mines Completes Strategic Partnership Transaction, Consolidating 100% Ownership of the Dos Amigos (formerly Domeyko Sulfuros) Copper-Gold Project in Chile
Published on 08/26/2026 at 04:15, 2 hours 7 minutes ago Shanghai Summer 2026 Makes the City Easier to Explore with New Travel, Payment and Visitor Services
Published on 08/26/2026 at 03:58, 2 hours 24 minutes ago EQS-Adhoc: AUSTRIACARD HOLDINGS AG: DAI NIPPON PRINTING CO., LTD. INTENDS TO PURSUE SQUEEZE-OUT AND DELISTING
Published on 08/26/2026 at 03:15, 3 hours 7 minutes ago Binzhou Unveils 'Trade-In' Housing Models to Stabilize Real Estate Market
Published on 08/25/2026 at 22:35, 7 hours 47 minutes ago ZOOPUNK Makes Its Opening Night Live Debut at gamescom 2026
Published on 08/25/2026 at 20:35, 9 hours 47 minutes ago Michter's Named the #1 Most Admired Whiskey in the World by Drinks International in New 2026 Ranking
Published on 08/25/2026 at 17:45, 12 hours 37 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 12 hours 37 minutes ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
Published on 08/25/2026 at 08:30, 21 hours 52 minutes ago Eiffage wins several contracts worth a total of €132 million in the healthcare sector
Published on 08/24/2026 at 18:00, 1 day 12 hours ago Outstanding shares and voting rights statement at 31 July 2026
Published on 08/24/2026 at 17:59, 1 day 12 hours ago Saint-Gobain strengthens its positioning in construction chemicals and light construction in Latin America
